Companies › CLOV
CLOVER HEALTH INVESTMENTS CO (CLOV)
Institutional ownership, SEC filings and insider activity
Sector: Financials · SEC CIK 0001801170 · EDGAR filings · Updated 2026-07-20
CLOVER HEALTH INVESTMENTS CO (CLOV) has reported institutional ownership of 24.4%, with 208 institutional managers holding positions valued at $224.6M per the latest 13F reporting period. SEC filings include an active material impairment disclosure (8-K Item 2.06), non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-20 — Insider transaction reported (Form 4)
- 2026-07-20 — Notice of proposed sale filed (Form 144)
- 2026-07-17 — Insider transaction reported (Form 4)
- 2026-07-17 — Notice of proposed sale filed (Form 144)
- 2026-07-17 — Current report (8-K) filed
- 2026-07-16 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, CLOVER HEALTH INVESTMENTS CO has 208 institutional holders and institutional ownership of 24.4%.
Insider activity
Insiders reported 102 transactions (4 buys, 16 sells) across 12 reporting insiders, with a net reported value of −$404.4K.
Data flags from SEC filings
Related companies
SIZZLE ACQUISITION CORP. II (SZZL) · PIONEER ACQUISITION I CORP (PACH) · PERIMETER ACQUISITION CORP I (PMTR) · Legato Merger Corp III (LEGT) · TRAILBLAZER ACQUISITION CORP (BLZR) · DONEGAL GROUP INC (DGICA)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-20.